Company Number: 14848685

Analysis Date: 2025-07-29 17:39 UTC

Certainly, let us conduct a thorough financial health assessment of NSPIC LIMITED, treating its financial data much like a medical examination to determine its overall wellbeing and prognosis.

---

1. Financial Health Score: Grade A-

Explanation:
NSPIC LIMITED displays strong financial "vital signs" for a newly incorporated company, with excellent liquidity and net asset position. The grade A- reflects a healthy financial start but acknowledges limited operational history and low cash holdings which merit monitoring.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Current Assets	256,832	Strong short-term resources, primarily debtors (trade receivables).
Cash at Bank	5,891	Low cash reserves; potential liquidity risk if cash needs immediate access.
Current Liabilities	8,065	Low short-term obligations; manageable relative to assets.
Net Current Assets (Working Capital)	248,767	Very healthy working capital indicating ability to cover short-term debts comfortably.
Net Assets (Equity)	249,363	Solid equity base for a new company, reflecting retained earnings and share capital.
Share Capital	695	Nominal initial capital investment, typical for start-ups.
Debtors (Trade Receivables)	250,941	High amount relative to cash; indicates funds tied up in receivables.

---

3. Symptoms Analysis

• Healthy Cash Flow Signs:
  The company has a strong net current asset position, meaning it holds significantly more current assets than liabilities, a good sign of short-term financial health. The equity base is solid, showing that the business is funded mainly through owner investment and retained earnings rather than debt.

• Symptoms of Distress:
  The cash balance is relatively low (£5,891) compared to the large debtor balance (£250,941). This suggests that a significant proportion of the company’s liquid resources are tied up in amounts owed by group undertakings or related parties. This can be likened to a patient having good blood volume but poor circulation — funds exist but are not immediately accessible as cash for operational needs.

• Operational History:
  NSPIC LIMITED is a very young company (incorporated May 2023), and these are its first accounts. The lack of historical data limits trend analysis. The company operates as a holding company (SIC 64209), which often involves managing investments rather than trading, explaining the high debtor balance (likely intra-group loans or receivables).

• Governance and Control:
  The sole director and 100% shareholder is Mr. Nicholas John Spragg, which centralizes control. This tight control can ensure swift decision-making but may carry risks if dependent on one individual.

---

4. Diagnosis

NSPIC LIMITED appears to be in a robust financial condition for its start-up phase, with a strong equity foundation and excellent working capital. The core "vital signs" indicate a financially sound entity with no immediate distress symptoms. However, the low cash balance juxtaposed with high debtors signals a liquidity bottleneck risk should those receivables not be converted into cash timely. This is a typical "early life" symptom for holding companies managing intercompany balances.

---

5. Prognosis

If NSPIC LIMITED maintains prudent management of its receivables and ensures sufficient cash flow for operational needs, its prognosis is positive. The company’s financial structure supports potential growth or further investment. However, future stability depends on:

• Effective collection or conversion of debtors into cash.
• Expansion of operational cash reserves.
• Monitoring for any emerging liabilities or cash flow pressures.

---

6. Recommendations

• Improve Cash Liquidity:
  Consider strategies to convert debtors into cash more rapidly, such as setting clear payment terms with group companies or arranging intra-group funding facilities.

• Cash Flow Forecasting:
  Implement regular cash flow forecasts to anticipate liquidity needs and avoid potential cash shortages.

• Diversify Capital Structure:
  While the current equity base is strong, consider planning for future capital injections or financing options to support expansion or unexpected expenses.

• Governance Oversight:
  Given the sole control by one director/shareholder, ensure robust governance practices and consider involving independent oversight or advisory to reduce concentration risk.

• Continue Compliance and Reporting:
  Maintain timely filing of accounts and confirmation statements as currently observed to avoid regulatory penalties and maintain stakeholder confidence.

---